Apitoxin is a new biological drug for pain & inflammation and arthritis, approved by the Korean FDA on May 3, 2003 after 14 years of preclinical, animal, and phase I, II & III clinical studies More
Anti-inflammatory drugs are commonly spread and used to treat pain, arthrosis, asthma or psoriasis. Our laboratory has developed a new molecule against these diseases with some interesting results. More
A method for reducing activity of inflammatory immune cells by exposure to selenium. Particularly, the invention relates to a method of short-term, high dose dietary selenium supplementation for treating a subject having an inflammatory disease,... More
Novel non-hydrolysable analogue of endogenous cannabinoids, which are found to be more potent therapeutic agents as they are more stable, for example, to hydrolytic cleavage in the gastrointestinal tract. Such compositions may be used as... More
cannabidiol (CBD) was found to b effective in reducing total area covered by artherosclerotic plaques (composed of the number and/or size of atherosclerotic plaques) in aortas and in lowering triglycerides, LDL and cholesterol levels in in-vivo... More
Displaying 1..10 of 17 -
per page
Next page
Order by
All rights reserved. Terms and Conditions | Contact us
